PVA

PSIVIDA CORP. - Announcements

0.00%

$2.99

Currently unlisted.

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

PVA	Appendix 3Y		23/11/09	55.29KB	Share
PVA	Appendix 3Y		23/11/09	45.07KB	Share
PVA	Appendix 3Y		23/11/09	44.81KB	Share
PVA	Appendix 3Y		23/11/09	49.4KB	Share
PVA	Results of Meeting		23/11/09	144.64KB	Share
PVA	Appendix 3Y		23/11/09	50.17KB	Share
PVA	pSivida Form 10Q SEC Quarterly Financial Report	PRICE SENSITIVE	16/11/09	216.99KB	Share
PVA	pSivida Q1 FY2010 Financial Reports	PRICE SENSITIVE	13/11/09	136.01KB	Share
PVA	pSivida Corporate Governance Report		12/11/09	153KB	Share
PVA	pSivida gives Q1 FY2010 Financials date and Conf. call info		06/11/09	101.17KB	Share
PVA	Appendix 3B		04/11/09	168.38KB	Share
PVA	pSivida's BrachySil Completes Pancreatic Dose Ranging Study	PRICE SENSITIVE	22/10/09	102.95KB	Share
PVA	pSivida completes followup of last patient in Iluvien trial	PRICE SENSITIVE	15/10/09	16.82KB	Share
PVA	Notice of Annual General Meeting/Proxy Form		14/10/09	406.5KB	Share
PVA	Appendix 3B		02/10/09	163.04KB	Share
PVA	pSivida PK Study interim results at 18 months for Iluvien	PRICE SENSITIVE	30/09/09	112.25KB	Share
PVA	Form 10K - Annual Report		28/09/09	622.08KB	Share
PVA	pSivida - 4th Qtr Results and Fiscal Yr Ended June 30, 2009	PRICE SENSITIVE	25/09/09	132.41KB	Share
PVA	pSivida Retinal Vein Occlusion Study Commences	PRICE SENSITIVE	24/09/09	77.83KB	Share
PVA	pSivida to present at Ophthalmic Drug Delivery Summit in US		21/09/09	75.7KB	Share
PVA	pSivida announces Q4 and Fiscal 2009 results release date		18/09/09	87.71KB	Share
PVA	pSivida to present at Rodman and Renshaw Conference in NYC		10/09/09	91.51KB	Share
PVA	Appendix 3B		09/09/09	149.33KB	Share
PVA	Appendix 3B		04/08/09	162.86KB	Share
PVA	Response to ASX Price Query	PRICE SENSITIVE	31/07/09	647.08KB	Share
PVA	Appendix 3B		03/07/09	154.5KB	Share
PVA	Form 4		01/07/09	27.47KB	Share
PVA	Form 4		01/07/09	33.1KB	Share
PVA	Iluvien device is VEGF inhibitor and Neuroprotectant in eyes	PRICE SENSITIVE	16/06/09	87.56KB	Share
PVA	Appendix 3B		03/06/09	163.47KB	Share
PVA	pSivida Earnings Report For Quarter Ended March 31, 2009	PRICE SENSITIVE	14/05/09	130.64KB	Share
PVA	Form 10-Q for the Quarter Ended March 31, 2009		14/05/09	275.79KB	Share
PVA	Appendix 3B		06/05/09	164.65KB	Share
PVA	pSivida technology featured in multiple abstracts at ARVO		24/04/09	91.82KB	Share
PVA	pSivida's Iluvien Study passes final DSMB Review		09/04/09	80.81KB	Share
PVA	Appendix 3B		03/04/09	164.09KB	Share
PVA	pSivida CEO to present at the IBC Ocular Angiogenisis Conf.		30/03/09	13.79KB	Share
PVA	CFO Resignation		13/03/09	94.21KB	Share
PVA	Favourable 12m Interim Results for Iluvien Human PK Study	PRICE SENSITIVE	13/03/09	101.69KB	Share
PVA	pSivida to present at the Cowen and Company Healthcare Conf		12/03/09	25.75KB	Share
PVA	Appendix 3B		10/03/09	165.84KB	Share
PVA	Enrollment complete in BrachySil Dose Ranging Study	PRICE SENSITIVE	05/03/09	97.11KB	Share
PVA	pSivida Earnings Report Q2, 2008		12/02/09	159.8KB	Share
PVA	Form 10-Q for the Quarter Ended Decemer 31, 2008	PRICE SENSITIVE	12/02/09	293.93KB	Share
PVA	pSivida ASX Waivers		03/02/09	105.42KB	Share
PVA	Appendix 3B		03/02/09	165.01KB	Share
PVA	pSivida appoints Dr. Paul Ashton as President and CEO		03/02/09	76.94KB	Share
PVA	Appendix 3B		07/01/09	165.79KB	Share
PVA	pSivida New Evaluation for Cardiovascular Drug Delivery	PRICE SENSITIVE	17/12/08	119.61KB	Share
PVA	pSivida new clinical trial for drug delivery device in AMD	PRICE SENSITIVE	12/12/08	120.37KB	Share
PVA	Appendix 3B		09/12/08	166.81KB	Share
PVA	pSivida BrachySil pancreatic cancer treatment on BBC doco.		03/12/08	102.74KB	Share
PVA	Response to ASX Appendix 3X Query		28/11/08	59.22KB	Share
PVA	Corporate Governance Report - Nov 2008		27/11/08	159.38KB	Share
PVA	Appendix 3X - Peter Savas		27/11/08	27.44KB	Share
PVA	Appendix 3Y - David Mazzo		27/11/08	42.21KB	Share
PVA	Appendix 3Y - Michael Rogers		27/11/08	41.38KB	Share
PVA	Appendix 3Y - Paul Ashton		27/11/08	46.61KB	Share
PVA	Appendix 3Y - Paul Hopper		27/11/08	37.19KB	Share
PVA	Appendix 3Y - Peter Savas		27/11/08	37.25KB	Share
PVA	Appendix 3Z - Katherine Woodthorpe		27/11/08	28.61KB	Share
PVA	Appendix 3X - Paul Hopper		27/11/08	27.41KB	Share
PVA	Appendix 3B		24/11/08	163.76KB	Share
PVA	Form 4		21/11/08	19.23KB	Share
PVA	Form 4		21/11/08	19.04KB	Share
PVA	Form 4		21/11/08	19.06KB	Share
PVA	Form 4		21/11/08	18.7KB	Share
PVA	Form 4		21/11/08	18.69KB	Share
PVA	Results of Annual Meeting November 2008		21/11/08	99.75KB	Share

PVAAppendix 3Y
23/11/09		55.29KB	Share
PVAAppendix 3Y
23/11/09		45.07KB	Share
PVAAppendix 3Y
23/11/09		44.81KB	Share
PVAAppendix 3Y
23/11/09		49.4KB	Share
PVAResults of Meeting
23/11/09		144.64KB	Share
PVAAppendix 3Y
23/11/09		50.17KB	Share
PVApSivida Form 10Q SEC Quarterly Financial Report
16/11/09	PRICE SENSITIVE	216.99KB	Share
PVApSivida Q1 FY2010 Financial Reports
13/11/09	PRICE SENSITIVE	136.01KB	Share
PVApSivida Corporate Governance Report
12/11/09		153KB	Share
PVApSivida gives Q1 FY2010 Financials date and Conf. call info
06/11/09		101.17KB	Share
PVAAppendix 3B
04/11/09		168.38KB	Share
PVApSivida's BrachySil Completes Pancreatic Dose Ranging Study
22/10/09	PRICE SENSITIVE	102.95KB	Share
PVApSivida completes followup of last patient in Iluvien trial
15/10/09	PRICE SENSITIVE	16.82KB	Share
PVANotice of Annual General Meeting/Proxy Form
14/10/09		406.5KB	Share
PVAAppendix 3B
02/10/09		163.04KB	Share
PVApSivida PK Study interim results at 18 months for Iluvien
30/09/09	PRICE SENSITIVE	112.25KB	Share
PVAForm 10K - Annual Report
28/09/09		622.08KB	Share
PVApSivida - 4th Qtr Results and Fiscal Yr Ended June 30, 2009
25/09/09	PRICE SENSITIVE	132.41KB	Share
PVApSivida Retinal Vein Occlusion Study Commences
24/09/09	PRICE SENSITIVE	77.83KB	Share
PVApSivida to present at Ophthalmic Drug Delivery Summit in US
21/09/09		75.7KB	Share
PVApSivida announces Q4 and Fiscal 2009 results release date
18/09/09		87.71KB	Share
PVApSivida to present at Rodman and Renshaw Conference in NYC
10/09/09		91.51KB	Share
PVAAppendix 3B
09/09/09		149.33KB	Share
PVAAppendix 3B
04/08/09		162.86KB	Share
PVAResponse to ASX Price Query
31/07/09	PRICE SENSITIVE	647.08KB	Share
PVAAppendix 3B
03/07/09		154.5KB	Share
PVAForm 4
01/07/09		27.47KB	Share
PVAForm 4
01/07/09		33.1KB	Share
PVAIluvien device is VEGF inhibitor and Neuroprotectant in eyes
16/06/09	PRICE SENSITIVE	87.56KB	Share
PVAAppendix 3B
03/06/09		163.47KB	Share
PVApSivida Earnings Report For Quarter Ended March 31, 2009
14/05/09	PRICE SENSITIVE	130.64KB	Share
PVAForm 10-Q for the Quarter Ended March 31, 2009
14/05/09		275.79KB	Share
PVAAppendix 3B
06/05/09		164.65KB	Share
PVApSivida technology featured in multiple abstracts at ARVO
24/04/09		91.82KB	Share
PVApSivida's Iluvien Study passes final DSMB Review
09/04/09		80.81KB	Share
PVAAppendix 3B
03/04/09		164.09KB	Share
PVApSivida CEO to present at the IBC Ocular Angiogenisis Conf.
30/03/09		13.79KB	Share
PVACFO Resignation
13/03/09		94.21KB	Share
PVAFavourable 12m Interim Results for Iluvien Human PK Study
13/03/09	PRICE SENSITIVE	101.69KB	Share
PVApSivida to present at the Cowen and Company Healthcare Conf
12/03/09		25.75KB	Share
PVAAppendix 3B
10/03/09		165.84KB	Share
PVAEnrollment complete in BrachySil Dose Ranging Study
05/03/09	PRICE SENSITIVE	97.11KB	Share
PVApSivida Earnings Report Q2, 2008
12/02/09		159.8KB	Share
PVAForm 10-Q for the Quarter Ended Decemer 31, 2008
12/02/09	PRICE SENSITIVE	293.93KB	Share
PVApSivida ASX Waivers
03/02/09		105.42KB	Share
PVAAppendix 3B
03/02/09		165.01KB	Share
PVApSivida appoints Dr. Paul Ashton as President and CEO
03/02/09		76.94KB	Share
PVAAppendix 3B
07/01/09		165.79KB	Share
PVApSivida New Evaluation for Cardiovascular Drug Delivery
17/12/08	PRICE SENSITIVE	119.61KB	Share
PVApSivida new clinical trial for drug delivery device in AMD
12/12/08	PRICE SENSITIVE	120.37KB	Share
PVAAppendix 3B
09/12/08		166.81KB	Share
PVApSivida BrachySil pancreatic cancer treatment on BBC doco.
03/12/08		102.74KB	Share
PVAResponse to ASX Appendix 3X Query
28/11/08		59.22KB	Share
PVACorporate Governance Report - Nov 2008
27/11/08		159.38KB	Share
PVAAppendix 3X - Peter Savas
27/11/08		27.44KB	Share
PVAAppendix 3Y - David Mazzo
27/11/08		42.21KB	Share
PVAAppendix 3Y - Michael Rogers
27/11/08		41.38KB	Share
PVAAppendix 3Y - Paul Ashton
27/11/08		46.61KB	Share
PVAAppendix 3Y - Paul Hopper
27/11/08		37.19KB	Share
PVAAppendix 3Y - Peter Savas
27/11/08		37.25KB	Share
PVAAppendix 3Z - Katherine Woodthorpe
27/11/08		28.61KB	Share
PVAAppendix 3X - Paul Hopper
27/11/08		27.41KB	Share
PVAAppendix 3B
24/11/08		163.76KB	Share
PVAForm 4
21/11/08		19.23KB	Share
PVAForm 4
21/11/08		19.04KB	Share
PVAForm 4
21/11/08		19.06KB	Share
PVAForm 4
21/11/08		18.7KB	Share
PVAForm 4
21/11/08		18.69KB	Share
PVAResults of Annual Meeting November 2008
21/11/08		99.75KB	Share

REFRESH

First 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

PSIVIDA CORP. - Announcements

Corporate SpotlightNot Yet Available

Announcements

Top Stories

Corporate Spotlight
Not Yet Available